Jason Lamar Aldred MD

PubMed

• Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.
  Wolfgang H Jost, Filip Bergquist, Andrew Evans, Sharon Hassin-Baer, Robert A Hauser
  Neurology and Therapy. 2026-05-07
• Foslevodopa/Foscarbidopa Subcutaneous Infusion Safety and Efficacy in Patients with and Without Prior Deep Brain Stimulation.
  Tove Henriksen, Juan Carlos Martínez-Castrillo, Mark H B Huisman, Sara Dhanani, Elizabeth Peckham
  Advances in Therapy. 2026-04-15
• 1 citations
  LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial.
  Omar S Mabrouk, Ben Tichler, H Moore Arnold, Eva C Thoma, Sara M Alexanian
  Nature Medicine. 2026-04-01

Journal Articles

• The past, present, and future of telemedicine for Parkinson's disease  
  Achey, M, Aldred, JL et al., Movement Disoders, 6/29/2014
• Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease  
  Aldred JL, Brod LS, Nutt JG, Movement Disorders, 5/2012

Books/Book Chapters

• Encyclopedia of Movement Disorders 
  Chapter: Levodopa. 
  Page 132 - 137Aldred, J. and Nutt, J.Editors: K. Kompoliti and L. Verhagen.Associated Press2010

Abstracts/Posters

• Levodopa-Carbidopa Intestinal Gel for the Treatment of Motor Fluctuations and Dyskinesia in Patients with Advanced Parkinson's Disease in a Real World Setting: Results...
  Standaert, D, Aldred, J et. al, XXIV World Congress of Neurology, Dubai, UAE, 7/2019
• Open Label Study of Pimavanserin in Patients with Comorbid Parkinson's Disease and Depression.
  Guskey, M, Aldred, J et al., Neuroscience Education Institute Congress, Colorado Springs, CO, USA, 2019
• Medication Use and In-Hospital Complications for Patients with Parkinson’s disease: A Retrospective Review. (Poster Presentation)
  Kerndt, T, Aldred J, et al., World Parkinson Congress, Montreal, Canada, 1/1/2013

Lectures

• DBS Update 
  La Crosse, WI - 1/1/2013
• Advances in Parkinson’s Care and Treatment 
  Wisconsin Dells, WI - 1/1/2013
• “Patient with Limited Response to Previous Toxin Therapies” 
  La Crosse, WI - 1/1/2012

Other

• Concept and Development of Department of Neurology and Residency Program Website 
  Aldred JL, Oregon Health and Science Neurology Department
  1/1/2005